First Hawaiian Bank’s Ironwood Pharmaceuticals IRWD Stock Holding History

First Hawaiian Bank’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-34,730	Closed	-$334K	–	877
2023 Q3	$334K	Hold	34,730	–	–	0.01%	677
2023 Q2	$370K	Hold	34,730	–	–	0.01%	677
2023 Q1	$365K	Hold	34,730	–	–	0.01%	680
2022 Q4	$430K	Hold	34,730	–	–	0.02%	600
2022 Q3	$360K	Hold	34,730	–	–	0.01%	624
2022 Q2	$400K	Hold	34,730	–	–	0.01%	618
2022 Q1	$437K	Hold	34,730	–	–	0.01%	658
2021 Q4	$405K	Sell	34,730 -505	-1%	-$6.2K	0.01%	692
2021 Q3	$460K	Buy	35,235 +505	+1%	+$6.53K	0.02%	540
2021 Q2	$447K	Hold	34,730	–	–	0.02%	564
2021 Q1	$388K	Hold	34,730	–	–	0.02%	628
2020 Q4	$396K	Buy	+34,730	New	+$380K	0.02%	569

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

First Hawaiian Bank's IRWD Position: Q4 2023 in Review

First Hawaiian Bank sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2023, closing a stake of 34,730 shares — an estimated $334K sold.

First Hawaiian Bank first reported a position in IRWD in Q4 2020 and held it in 12 quarters. The position peaked at $460K in Q3 2021. 251 funds tracked by Wall St. Rank hold IRWD as of Q4 2023.

First Hawaiian Bank reported no remaining Ironwood Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
First Hawaiian Bank sold 34,730 Ironwood Pharmaceuticals shares in Q4 2023, an estimated $334K.
First Hawaiian Bank first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 12 quarters.
First Hawaiian Bank's Ironwood Pharmaceuticals position peaked at $460K in Q3 2021.
251 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2023.

Based on First Hawaiian Bank's 13F filing for Q4 2023, filed 9 Jan 2024.